C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2004
10/13/2004	EP1466925A1 Antibodies against fibroblast growth factor 23
10/13/2004	EP1466529A1 Composition with heart rate reducing properties
10/13/2004	EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
10/13/2004	EP1465988A2 Myo-inositol oxygenases
10/13/2004	EP1465985A2 High level cytokine production with enhanced cell viability
10/13/2004	EP1465928A2 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
10/13/2004	EP1465926A2 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
10/13/2004	EP1465925A2 Antibodies that immunospecifically bind to trail receptors
10/13/2004	EP1465916A2 Novel g proein-coupled receptor, gave7
10/13/2004	EP1465912A2 Novel chimeric tnf ligands
10/13/2004	EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins
10/13/2004	EP1286682A4 Methods and compositions for inhibiting immunoglobulin-mediated--reperfusion injury
10/13/2004	EP1135166B1 Hapten-carrier conjugates for treating and preventing nicotine addiction
10/13/2004	EP0937155B1 Resistance against nematodes and/or aphids
10/13/2004	EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases
10/13/2004	EP0817847B1 Il-17 receptor
10/13/2004	EP0788549B1 Regulatory nucleic acid sequences and uses thereof
10/13/2004	EP0739353B1 Bacterial receptor structures
10/13/2004	EP0736096B1 Antimicrobial proteins
10/13/2004	EP0688361B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/13/2004	EP0666915B1 The pct-65 serotonin receptor
10/13/2004	EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof
10/13/2004	CN1537117A 干扰素γ多肽变体 IFN-γ polypeptide variant
10/13/2004	CN1537111A Urea substituted imidazoquinolines
10/13/2004	CN1536089A Promotor for expressing gene in fungal cell
10/13/2004	CN1536082A Coding gene of hirudin mutant and high-effective expression strain
10/13/2004	CN1535984A Human liver regeneration promoting factor and its expression
10/13/2004	CN1170931C Vasculogenesis correlation molecule
10/13/2004	CN1170594C 弯曲菌疫苗 Campylobacter vaccine
10/12/2004	US6803453 Using antibodies directed to a novel class or family of transforming growth factor (tgf)-beta binding proteins; for diagnosis, prevention, treatment of osteoporosis
10/12/2004	US6803450 Fusion protein; genetic engineering; energy storage
10/12/2004	US6803449 Polypeptide for use in the diagnosis and treatment viral diseases
10/12/2004	US6803232 Neuropeptide y (npy) receptor (designated npy- y7) used to express the receptor in cells which can then be used for drug screening
10/12/2004	US6803225 Expression vector for use transformation of yeast cells
10/12/2004	US6803214 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
10/12/2004	US6803213 Having one or more amino acid substitutions that confer receptor agonist or antagonist properties
10/12/2004	US6803212 Low oxygen affinity mutant hemoglobins
10/12/2004	US6803210 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter
10/12/2004	US6803209 Nutrient for use in the propagation of microorganism and the generation of heterologous proteins
10/12/2004	US6803199 Thyroid sodium/iodide symporter and nucleic acid encoding same
10/12/2004	US6803189 Methods for the detection of cervical cancer
10/12/2004	US6803062 Process for producing hydrolyzed protein
10/12/2004	US6803039 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM
10/12/2004	US6802966 Complex of metal oxide and alcohol
10/12/2004	CA2387401C Compositions, methods and systems for the production of enediynes
10/07/2004	WO2004085666A2 Secreted proteins
10/07/2004	WO2004085664A2 Process for the preparation of angiotensin converting enzyme (ace) inhibitors and its use
10/07/2004	WO2004085649A1 Prfb factor (peptide chain release factor b) from bacillus licheniformis and the utilization thereof for enhancing the protein formation rate
10/07/2004	WO2004085623A2 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
10/07/2004	WO2004085463A2 Methods of unnatural amino acid incorporation in proteins in mammalian cells
10/07/2004	WO2004084831A2 Optimized expression of hpv 31 l1 in yeast
10/07/2004	WO2004084808A2 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
10/07/2004	WO2004074432A9 Antibody vaccine conjugates and uses therefor
10/07/2004	WO2004045517A3 Method for the diagnosis and treatment of vascular disease
10/07/2004	WO2004038375A3 Water soluble toxin produced by pfiesteria species
10/07/2004	WO2004035757A3 Protein synthesis using modified ribosomes
10/07/2004	WO2004026427A3 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds
10/07/2004	WO2004020585B1 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
10/07/2004	WO2004013303A3 Modified annexin proteins and methods for treating vaso-occlusive sickle-cell disease
10/07/2004	WO2003092619A3 Prevention and treatment of type 2 diabetes
10/07/2004	WO2003070981A8 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
10/07/2004	WO2003066818A3 Secretion, transcription and sporulation genes in bacillus clausii
10/07/2004	WO2003033662A3 Protection against oxidative stress and inflammation by a cytoprotective response element
10/07/2004	WO2002092000A3 Hbm variants that modulate bone mass and lipid levels
10/07/2004	WO2002068451A3 Sperm protein 17 for the diagnosis and treatment of cancer
10/07/2004	US20040199945 Preparing heavy chain binding protein microarray in plant cells via genetic transformation and gene expression; tissue engineering; diagnostic antibody microarrays
10/07/2004	US20040199939 Modified cry3a toxins and nucleic acid sequences coding therefor
10/07/2004	US20040199414 Anonymous competition entry
10/07/2004	US20040198961 Fce fusion proteins for treatment of allergy and asthma
10/07/2004	US20040198960 Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae
10/07/2004	US20040198959 Acetyllysine-recognizing monoclonal antibody and process for producing the same
10/07/2004	US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy
10/07/2004	US20040197871 for diagnosing and treating inflammatory bowel disease using purified polypeptide; genetic engineering
10/07/2004	US20040197864 Derivatives of magainin and methods of production thereof
10/07/2004	US20040197863 for use as anticancer/tumor agents using real-time polymerase chain reaction genetic engineering
10/07/2004	US20040197861 receptor-based gene expression modulation system for drug screening; genetic engineering
10/07/2004	US20040197854 nucleic acid construct integrates into the host genome at a locus not within the DNA sequence of interest to produce a mutant cell
10/07/2004	US20040197853 largely reduced of antigenicity compared to native trichosanthin (TCS), while retaining anti-tumor, anti-virus, abortifacient, and ribosome-inactivating protein activities; for treating leukemia
10/07/2004	US20040197851 Two-stage protective groups for the synthesis of biopolymers
10/07/2004	US20040197842 for monitoring patients in vitro over time which can reveal changes in risk for hypercoagulation or other coagulopathies and/or effectiveness of anticoagulant therapy
10/07/2004	US20040197838 for creating this postranslational modification in vivo; genetic engineering; solid phase synthesis; kits
10/07/2004	US20040197823 Compositions and methods for aa4rp assay
10/07/2004	US20040197783 Comprises nucleotide sequences coding modulator for treatment and prevention of tumor disorders; antisense/antitumor agents; immunotherapy
10/07/2004	US20040197346 Materials and methods for intracellular transport and their uses
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197332 antiproliferative agents; antitumor and anticancer agents; monoclonal antibodies produced by hybridomas cell ling
10/07/2004	US20040197327 Administering antagonist of receptor on surface of lymphocytes; therapy for multiple sclerosis; antidiabetic agents
10/07/2004	US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses
10/07/2004	DE102004013282A1 ELISA-Kits zum Nachweis von Kollagenase 3 als Proenzym und in aktivierter Form in Körperflüssigkeiten und Zellkulturüberständen ELISA kits for the detection of collagenase 3 as a proenzyme and in activated form in body fluids and cell culture supernatants
10/06/2004	EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases
10/06/2004	EP1464702A1 Method of stabilizing protein
10/06/2004	EP1463942A2 Methods for purifying protein
10/06/2004	EP1463817A2 Histamine receptor h3 polynucleotides
10/06/2004	EP1463807A2 Pichia pastoris formate dehydrogenase and uses therefor
10/06/2004	EP1463806A2 Novel cyclooxygenase variants and methods of use
10/06/2004	EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof

1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 1125